A petition urges the FDA to allow certain radiology AI software updates via postmarket study requirements instead of new 510(k) applications.
Key Details
- 1Petition submitted to the FDA seeks a streamlined pathway for radiology AI software with prior 510(k) clearance.
- 2Proposal targets CADx, CADe/x, CADt, and medical image analyzer software types under specified FDA regulations.
- 3Vendors with cleared devices could forgo new 510(k) submissions for new features, provided robust postmarket measures are in place.
- 4Existing 510(k) pathway would remain as an option; the new pathway would be partially exempt under defined conditions.
- 5FDA is accepting comments on the proposal until February 27, 2026.
- 6The proposal aims to close the 'innovation gap' between the U.S. and other regions, citing more limited AI diagnostic offerings in the U.S.
Why It Matters
If adopted, this pathway could accelerate the deployment of AI innovations in U.S. radiology by reducing regulatory redundancy, addressing concerns about lagging AI adoption compared to Europe. It signals ongoing regulatory evolution in medical imaging AI oversight.
Source
AuntMinnie
Related News
•HealthExec
EFF Sues CMS For Transparency on AI-Powered Medicare Prior Authorization
EFF has sued CMS to compel disclosure about the WISeR pilot deploying AI for Medicare prior authorization.
•Radiology Business
UCLA Appoints Inaugural Associate Dean for Health AI Strategy
UCLA has appointed Katherine P. Andriole as its first associate dean for Health AI Strategy and Innovation, with an initial focus on radiology.
•Radiology Business
AI Tool Developed to Detect Domestic Violence via Radiology Data
Mass General radiologists developed a machine learning tool to identify patients at risk of intimate partner violence using imaging and clinical records.